{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"tropical-spastic-paraparesis","columns":[{"gene":"","key":"population-6808d4aaf0f4e269da48","label":"Myelopathy, htlv-1-associated","mondoId":"MONDO:0008039","onsetQualifier":null,"originColumnKey":"MONDO:0008039/OMIM:159580","originalViews":[{"key":"MONDO:0008039/OMIM:159580","label":"Myelopathy, htlv-1-associated","scopeLabel":"OMIM:159580","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["86d2aa35640751b8ba6dba06b6c3d14c702e82789598dc5660cf8e6c7c83fe4a","ef399d490f9d766356794d46e213c5cf99a6b024eca3d56bd14527e5ac6e3eb6","f3ec47329301e98c93f90c7bd0b2b3e1216d5abed07a8c0e18af43ab172c080d"],"recordQualifiers":{},"scopeLabel":"OMIM:159580","sourceIds":["OMIM:159580"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6808d4aaf0f4e269da48"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007256","HP:0002196","HP:0002313"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":3}},"features":[{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0002196","label":"Myelopathy","primary":true},{"hpoId":"HP:0002313","label":"Spastic paraparesis","primary":true}],"ledeHtml":"Tropical spastic paraparesis is a chronic systemic immune-mediated inflammatory myeloneuropathy, more frequently reported in women than in men, that usually presents in adulthood with slowly progressive spastic paraparesis of the lower limbs, bladder and bowel dysfunction, and sensory disturbances in the lower extremities (e.g. paresthesia and dysesthesia) and that is associated with a human T-cell lymphotropic virus type 1 (HTLV-1) infection.","mondoId":"MONDO:0008039","node":{"canonicalSlug":"tropical-spastic-paraparesis","comparisons":[{"documentSha256":"75f9ee18e663d06c328cc882f2a50fa861cfa90e20ab9dba51dbae8973330b02","key":"legacy-tropical-spastic-paraparesis","kind":"legacy","label":"tropical spastic paraparesis","memberIds":["MONDO:0008039"],"mondoId":"MONDO:0008039","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/tropical-spastic-paraparesis.75f9ee18e663d06c328cc882f2a50fa861cfa90e20ab9dba51dbae8973330b02.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"tropical spastic paraparesis","paragraphs":["Tropical spastic paraparesis is a chronic systemic immune-mediated inflammatory myeloneuropathy, more frequently reported in women than in men, that usually presents in adulthood with slowly progressive spastic paraparesis of the lower limbs, bladder and bowel dysfunction, and sensory disturbances in the lower extremities (e.g. paresthesia and dysesthesia) and that is associated with a human T-cell lymphotropic virus type 1 (HTLV-1) infection."],"scope":"exact","source":"MONDO","upstream":"Orphanet:289326","url":"https://monarchinitiative.org/MONDO:0008039"},"ownColumnKeys":["population-6808d4aaf0f4e269da48"],"publication":"published","relationships":[{"kind":"parent","label":"human T-lymphotropic virus 1 infectious disease","mondoId":"MONDO:0005801","slug":"human-t-lymphotropic-virus-1-infectious-disease"},{"kind":"parent","label":"infectious disorder of the nervous system","mondoId":"MONDO:0020010","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/8208"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"86d2aa35640751b8ba6dba06b6c3d14c702e82789598dc5660cf8e6c7c83fe4a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:159580","disease_name":"Myelopathy, htlv-1-associated","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"OMIM:159580","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ef399d490f9d766356794d46e213c5cf99a6b024eca3d56bd14527e5ac6e3eb6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:159580","disease_name":"Myelopathy, htlv-1-associated","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002196","is_excluded":false,"label":"Myelopathy","onset_id":null,"reference":"OMIM:159580","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f3ec47329301e98c93f90c7bd0b2b3e1216d5abed07a8c0e18af43ab172c080d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:159580","disease_name":"Myelopathy, htlv-1-associated","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002313","is_excluded":false,"label":"Spastic paraparesis","onset_id":null,"reference":"OMIM:159580","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008039\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:289326</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Tropical spastic paraparesis is a chronic systemic immune-mediated inflammatory myeloneuropathy, more frequently reported in women than in men, that usually presents in adulthood with slowly progressive spastic paraparesis of the lower limbs, bladder and bowel dysfunction, and sensory disturbances in the lower extremities (e.g. paresthesia and dysesthesia) and that is associated with a human T-cell lymphotropic virus type 1 (HTLV-1) infection.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0008039\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"tropical-spastic-paraparesis","sourceDocuments":[{"name":"MONDO: tropical spastic paraparesis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0008039"}],"sourceNote":"","synonyms":["ham","HAM/TSP","ham/TSP","HTLV-1 associated myelopathy/tropical spastic paraparesis","HTLV-1-associated myelopathy/tropical spastic paraparesis","Human T-cell leukaemia virus type 1 associated myelopathy/tropical spastic paraparesis","Human T-cell leukemia virus type 1 associated myelopathy/tropical spastic paraparesis","Human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis","Human T-lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis","myelopathy, HTLV-1-associated","tropical spastic paraparesis (formerly)","tropical spastic paraplegia","TSP"],"takeawayHtml":"","title":"tropical spastic paraparesis"},"schemaVersion":1}
